3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
7
Infections
7
Lymphoma
6
Prostatic Neoplasms
5
Neutropenia
5
Leukemia
5
Neoplasms, Plasma Cell
4
Lymphoma, Non-Hodgkin
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myeloid, Acute
3
Febrile Neutropenia
3
Waldenstrom Macroglobulinemia
2
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Pancreatic Cyst
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Intraocular Lymphoma
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Interventions
Indocyanine Green
2
Ileostomy
2
Bioseal
2
Water
1
Tobramycin
1
Tissue Adhesives
1
Surgical Procedures, Operative
1
Surgical Fixation Devices
1
Somatostatin
1
Sodium Chloride
1
Serum Albumin, Human
1
Saline Solution
1
Robotic Surgical Procedures
1
Neomycin
1
Metronidazole
1
Methods
1
Levofloxacin
1
Inulin
1
Fluorescein Angiography
1
Fibrin Tissue Adhesive
1
Esophagectomy
1
Enoxaparin
1
Endoscopy
1
Enbucrilate
1
Diet
1
Congresses as Topic
1
Colistin
1
Ciprofloxacin
1
Cathartics
1
Amphotericin B
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Anastomotic Leak
×
Ciprofloxacin
×
Clear all
NCT02682485
2023-04-26
SES-DTA
University of Chicago
Phase 2
Withdrawn